Morristown, NJ – August, 2022 – OCLI Vision and Spectrum Vision Partners are delighted to announce their most recent acquisition of Morristown Ophthalmology Associates, P.A. The esteemed Jeffrey Reisman, M.D., Cristin Subramaniam, M.D., Ezra Kazam, MD, Robert Barone MD, FACS and Amy Jasani, OD, join the expanding OCLI Vision network. Morristown Ophthalmology Associates, P.A. is SVP’s 22nd acquisition.
OCLI Vision is a leading ophthalmology practice whose growth is supported by the management and administrative services of Spectrum Vision Partners (SVP), an organization serving many of the top ophthalmologists, optometrists, and ambulatory eye surgery centers in New York, New Jersey, Connecticut, Pennsylvania, and West Virginia.
“We are very pleased to welcome Morristown Ophthalmology Associates to OCLI Vision,” says Tom Burke, SVP’s CEO. “The team at Morristown fully aligns with our goals of providing outstanding eye care to the populations we serve”.
Morristown Ophthalmology Associates have proudly served the community of Morris County, New Jersey since 1972. The practice is the earliest and most established practice, of continuous existence, in all of Morristown. For over 40 years, the Morristown physicians have strived to maintain the highest quality of comprehensive eye care. Services offered include Lasik, premium and traditional cataract surgery, comprehensive eye care, retina services, glaucoma treatment, cornea services and facial rejuvenation.
“Morristown is committed to providing the highest level of care possible, our goals and vision align perfectly with OCLI Vision and their renowned providers and surgeons” said Jeffrey Reisman, MD.
Morriston Ophthalmology Associates is located at 131 Madison Avenue, Suite 130 Morristown, NJ 07960.
Cross Keys Capital Investment Banking acted as exclusive financial advisor to Morristown Ophthalmology Associates. Cross Keys Capital provides clients with a full suite of investment banking advisory services including sell-side and buy-side M&A, recapitalizations, restructurings, and capital raising.
Chief Executive Officer
Chief Development Officer
About OCLI Vision
Founded in 1997, OCLI Vision (www.ocli.net) is one of the leading ophthalmology practices in the United States. The practices of OCLI Vision offer eye care services at locations throughout Connecticut, New Jersey, New York, Pennsylvania, and West Virginia. OCLI Vision is led by a large group of highly skilled ophthalmologists and optometrists in each major sub-specialty of eye care who provide comprehensive eye care services, including treatment for cataracts, corneal disease, glaucoma, retinal disease, oculoplastics, refractive surgery, and neuro-ophthalmology.
About Spectrum Vision Partners
Spectrum Vision Partners (SVP) (www.spectrumvisionpartners.com) is a leading management services organization, serving the ophthalmology sector. With nearly 1,300 employees providing world-class practice management and administrative solutions to a network of nationally renowned, multi-specialty ophthalmologists in New York, New Jersey, Connecticut, Pennsylvania and West Virginia, SVP supports more than 45 clinic locations, five state-licensed ambulatory surgery centers, six refractive suites, and over 110 surgeons, doctors and other medical professionals. SVP provides a comprehensive set of business support functions, including billing and collections, credential services, marketing, physician recruitment, ASC development, financial and accounting services, benefits and payroll management and information technology. The company’s corporate service center is located at 825 East Gate Boulevard, Suite 111, Garden City, NY 11530.
About Blue Sea Capital Blue Sea Capital (www.blueseacapital.com) is a private equity firm based in West Palm Beach, Florida, that invests in growth-oriented lower middle market companies valued up to $250 million. The firm has more than $750 million in assets under management and invests across three industry verticals: aerospace & defense, healthcare, and industrial growth. Blue Sea Capital’s strategy is to partner with talented managers and differentiated companies, typically as the first or second institutional investor, and deliver strategic and operational value-add that drives growth acceleration, industry outperformance and business transformation.